Skip to main content

Byrne Asset Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1911322 KINGSTON, NJ

Position in GILD

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$313,954
-$35,167 QoQ
Shares Held
2,485
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,623
of 2,266 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Byrne Asset Management LLC holds $7,638,539 across 9 Drug Manufacturers - General names. GILD ranks #7 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
2,485 $313,954

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $313,954 2,485
2026-03-31 $349,121 2,505
2025-12-31 $314,214 2,560
2025-09-30 $290,820 2,620
2025-06-30 $301,566 2,720
2025-03-31 $331,668 2,960
2024-12-31 $298,355 3,230
2024-09-30 $295,116 3,520
2024-06-30 $249,260 3,633
2024-03-31 $894,016 12,205
2023-12-31 $1,020,077 12,592
2023-09-30 $950,389 12,682
2023-06-30 $1,030,580 13,372
2023-03-31 $1,080,850 13,027
2022-12-31 $1,170,307 13,632
2022-09-30 $935,960 15,172
2022-06-30 $950,452 15,377
2022-03-31 $899,300 15,127
2021-12-31 $896,878 12,352